Programa de estimulación temprana Síndrome X Frágil

La Estimulación Temprana es el conjunto de técnicas utilizadas para potenciar al máximo el desarrollo y las habilidades de socialización, lenguaje, autoayuda, cognitivas y psicomotrices. Este trabajo tiene como objetivo la planificación y posterior ejecución de un programa de Estimulación Temprana, dirigido en este caso concreto a un niño de 4 años y 4 meses diagnosticado con el Síndrome X Frágil. Tras el estudio de la patología y el establecimiento de la línea base de intervención, se decide intervenir en el área de socialización de usuario. Para ello, se han establecido diversas actividades centradas en potenciar las conductas de interacción social del niño, como el saludo y la despedida, la sonrisa social, las conductas de aproximación y el lenguaje. Los resultados obtenidos muestran una buena progresión con respecto a los objetivos planteado inicialmente, sin embargo, será necesaria la planificación de un nuevo programa de intervención puesto que no se han logrado en su totalidad los objetivos propuestos.Early Stimulation is a group of techniques used to improve the development and the abilities of socialization, language, self-help, cognitive and psychomotor. The objective of this project is the planning and subsequent execution of an early stimulation program, directed to a four years old boy with a diagnosis of fragile X syndrome. After studying the pathology and establishing the baseline intervention, it is decided to intervene in the socialization area. To do this, several activities are established focused on improve and promote interaction behavior, such as greeting, farewell, social smile, approach behavior and language. The results show an improvement in relation to the objectives. However, it will be necessary the planning of a new intervention program, in order to achieve the objectives totally

App Street Racket. Aprendiendo a jugar de forma digital

Experiencia didáctica sobre el deporte alternativo denominado Street Racket en las clases de Educación Física de la etapa de Educación Primari

El BreakoutEDU como herramienta lúdico didáctica en la formación permanente del profesorado

Experiencia didáctica sobre el breakoutEDU y la gamificación en la formación del profesorado de educación primaria y educación secundaria de la Comunidad Valenciana

Diseño e implementación de una rúbrica para la evaluación de casos prácticos en derecho procesal

Memoria ID-089 Ayudas de la Universidad de Salamanca para la innovación docente, curso 2020-2021

Club de lectura de jurisprudencia

Memoria ID-012. Ayudas de la Universidad de Salamanca para la innovación docente, curso 2019-2020

Active and Passive Tuning of Ultranarrow Resonances in Polaritonic Nanoantennas

[EN] Optical nanoantennas are of great importance for photonic devices and spectroscopy due to their capability of squeezing light at the nanoscale and enhancing light-matter interactions. Among them, nanoantennas made of polar crystals supporting phonon polaritons (phononic nanoantennas) exhibit the highest quality factors. This is due to the low optical losses inherent in these materials, which, however, hinder the spectral tuning of the nanoantennas due to their dielectric nature. Here, active and passive tuning of ultranarrow resonances in phononic nanoantennas is realized over a wide spectral range (approximate to 35 cm(-1), being the resonance linewidth approximate to 9 cm(-1)), monitored by near-field nanoscopy. To do that, the local environment of a single nanoantenna made of hexagonal boron nitride is modified by placing it on different polar substrates, such as quartz and 4H-silicon carbide, or covering it with layers of a high-refractive-index van der Waals crystal (WSe2). Importantly, active tuning of the nanoantenna polaritonic resonances is demonstrated by placing it on top of a gated graphene monolayer in which the Fermi energy is varied. This work presents the realization of tunable polaritonic nanoantennas with ultranarrow resonances, which can find applications in active nanooptics and (bio)sensing.J.M.-S. acknowledges financial support from the Ramon y Cajal Program of the Government of Spain and FSE (Grant No. RYC2018-026196-I) and the Spanish Ministry of Science and Innovation (State Plan for Scientific and Technical Research and Innovation Grant Number PID2019-110308GA-I00). P.A.-G. acknowledges support from the European Research Council under starting Grant No. 715496, 2DNANOPTICA, and the Spanish Ministry of Science and Innovation (State Plan for Scientific and Technical Research and Innovation Grant Number PID2019-111156GB-I00). G.a.-P. and J.T.-G. acknowledge support through the Severo Ochoa Program from the Government of the Principality of Asturias (Grant nos. PA20-PF-BP19-053 and PA-18-PF-BP17-126, respectively). A.Y.N. acknowledges the Spanish Ministry of Science and Innovation (Grant Nos. MAT201788358-C3-3-R and PID2020-115221GB-C42) and the Basque Department of Education (Grant No. PIBA-2020-1-0014) J.H.E. acknowledges support for h-BN crystal growth from the National Science Foundation, Award Number CMMI-1538127. R.H. acknowledges financial support from the Spanish Ministry of Science, Innovation and Universities (National Project Grant No. RTI2018-094830-B-100 and the Project Grant No. MDM-2016-0618 of the Marie de Maeztu Units of Excellence Program), the Basque Government (Grant No. IT1164-19), and the European Union's Horizon 2020 research and innovation programme under the Graphene Flagship (Grant Agreement Numbers 785219 and 881603, GrapheneCore2 and GrapheneCore3). I.D. acknowledges the Basque Government (Grant No. PRE_2019_2_0164). Work at MIT was partly supported through AFOSR Grant No. FA9550-16-1-0382, through the NSF QII-TAQS program (Grant No. 1936263), and the Gordon and Betty Moore Foundation EPiQS Initiative through Grant No. GBMF9643 to P.J.-H

Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis

Introduction Uveitis is the inflammation of the middle layer of the eye, the uvea, and is a major cause of blindness. None of the instruments used in clinical practice are, in themselves, sufficient to evaluate the course of uveitis. Therefore, it is necessary to develop instruments enabling standardized measurement of inflammatory activity. We developed a composite disease activity index for patients with uveitis known as UVEDAI, which considers the overall activity of the eye. The objective of this study was to validate the composite index of ocular inflammation, UVEDAI. Methods A multicenter cross-sectional study involving eight Spanish tertiary hospitals. Sixty-two patients aged ≥ 18 years with acute uveitis were recruited. Participants gave informed consent before participating in the study. A full ophthalmological examination was performed by two ophthalmologists to determine inflammatory activity: one used the UVEDAI score and the other used clinical judgment. The ophthalmologists did not share their findings with each other to avoid introducing bias into the analysis. Construct validity was established by means of factor analysis. The criterion validity of the index was determined using an ordinal multivariate regression model, in which the dependent variable was the degree of uveal inflammation (mild, moderate, or high/severe). Cut-off points were determined for the UVEDAI and for the receiver operating characteristic (ROC) curves. Results Sixty-two patients were included. Total variance with the three components accounted for 80.32% of the construct validity. Each of the three components identified one type of eye involvement. The discriminatory capacity of UVEDAI was 0.867 (95% CI 0.778; 0.955 p < 0.001) for mild versus moderate–high and 0.946 (95% CI 0.879; 1.000 p < 0.001) for high versus mild–moderate. Conclusions The variables included in UVEDAI enable ocular inflammatory activity to be described with a high degree of accuracy. The index may be used to evaluate and classify this activity with considerable discriminatory power.We would like to acknowledge the support of Abbvie: this study was conducted with an unrestricted grant from Abbvie. The Spanish Society of Rheumatology is the sponser and funder of this study and the journal's Rapid Service Fee, and has participated in the study design; in the analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. The corresponding author had full access to all study data and had final responsibility for the decision to submit the manuscript for publication